Perennial Allergic Rhinitis Market is expected to grow at a CAGR of 5.28% during the forecast period. Perennial Allergic Rhinitis Market is expected to reach US$ 9.25 Bn. by 2029.Perennial Allergic Rhinitis Market Overview:
Rhinitis is broadly defined as inflammation of the nasal mucosa, which is a common disorder that affects up to 40% of the global population. Allergic rhinitis is the most common type of chronic rhinitis, affecting 10 to 20% of the population and evidence suggests that the prevalence of the disorder is increasing.To know about the Research Methodology :- Request Free Sample Report It occurs due to various allergy propelling factors like pollen grains, dust, mist, fog, and other airborne allergens. After the inhalation of these allergens, the production of IgE is triggered, which releases the mediators such as histamine leading to irritation and inflammation of the mucous membrane. Major symptoms of the disease are sneezing, itching, nasal obstruction, congestion, and rhinorrhea. According to the study, allergen provocation of the upper airways leads to local inflammatory response for upper as well as lower airways. This supports the fact that rhinitis and asthma frequently co-exist. The report covers the detailed analysis of global Perennial Allergic Rhinitis industry with the classifications of the market on the drug class, route of administration and distribution channel. Analysis of past market dynamics from 2017 to 2021 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key players contribution in it. The report has profiled fourteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost of treatment, availability of advanced technology are analysed and report has come up with recommendations for future hot spot in APAC region.
Perennial Allergic Rhinitis Market Dynamics:
Ongoing extensive R&D activities for the development of more effective products and formulations, changes in environmental conditions, increasing pollution, rising number of patients, changes in lifestyle are proving the major driving factors for the perennial allergic rhinitis market. Increasing respiratory disorders, rise in consumption of tobacco, and smoking habits are also having a high impact in propelling the market. Currently, approximately 10 to 30% of adults and 40% of children are affected. The European Community Respiratory Health survey recorded a prevalence of 10 to 41% in adults with allergic rhinitis. Despite these drivers, as major patent generic drugs are on a verge of expiration is expected to restrict the market growth. Also, the availability and adoption of alternative treatment modes are also expected to hamper the market growth.Perennial Allergic Rhinitis Market Regional Insights:
Europe region is the most dominant market, which held the largest market of xx% in 2013 and expected to continue the dominance throughout the forecast period owing to the increasing number of patient pool and high awareness. According to few large-scale standardized studies, the European Community Respiratory Health Survey (ECRHS) found that the prevalence of allergic rhinitis in Europe for adult population was 21%. The Asia Pacific is expected to show remarkable development owing to rising patient’s awareness, growing prevalence of the disorder, presence of high unmet needs, and growing healthcare infrastructure. The prevalence of allergic diseases in Asia varied widely but was found to be rising (asthma 29.1%; AR up to 45%) mostly in low- and middle-income countries. In Japan, rhinitis has increased from 3.8% in 1982 to 32% and asthma from 4.6% in 1992.Scope of global Perennial Allergic Rhinitis Market :Inquire before buying
Global Perennial Allergic Rhinitis Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 6.13 Bn. Forecast Period 2022 to 2029 CAGR: 5.28% Market Size in 2029: US $ 9.25 Bn. Segments Covered: by Drug-Class • Anti-Histamines • Steroids • Decongestants • Allergen Immunotherapy formulations • Others by Route of Administration • Oral • Nasal • Intraocular • Intravenous by Distribution Channels • Hospital pharmacies • Retail pharmacies • Online stores Global Perennial Allergic Rhinitis Market Segment Analysis:
The segment of antihistamines are the most rapidly growing segment. It held the largest market share of approximately 20% in 2018 and is expected to register a CAGR of 8.7% during the forecast period. The newer, non-sedating, second-generation oral antihistamines (e.g., desloratadine [Aerius], fexofenadine [Allegra], and loratadine [Claritin]) are the first-line pharmacological treatments recommended for all patients with allergic rhinitis. These agents have been found to effectively reduce sneezing, itching, and rhinorrhea when taken regularly at the time of maximal symptoms or before exposure to an allergen.Key players operating in global Perennial Allergic Rhinitis Market:
• Alcon Inc. • Merck & Co. Inc. • Biopharma • Sumitomo Pharma Co. • Genentech Inc. • Pfizer Inc. • Hanmi Pharmaceuticals Inc. • Hisamitsu Pharmaceutical Co. • Teva pharmaceutical • GlaxoSmithKline PLC • Sanofi S.A. • Johnson & Johnson • AstraZeneca • Boehringer Ingelheim Frequently Asked Questions: 1. Which region has the largest share in Global Perennial Allergic Rhinitis Market? Ans: Asia Pacific region holds the highest share in 2021. 2. What is the growth rate of Global Perennial Allergic Rhinitis Market? Ans: The Global Perennial Allergic Rhinitis Market is growing at a CAGR of 5.28% during forecasting period 2022-2029. 3. What is scope of the Global Perennial Allergic Rhinitis Market report? Ans: Global Perennial Allergic Rhinitis Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What is the study period of this market? Ans: The Global Perennial Allergic Rhinitis Market is studied from 2021 to 2029.
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: PERENNIAL ALLERGIC RHINITIS Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global PERENNIAL ALLERGIC RHINITIS Market Analysis and Forecast 6.1. PERENNIAL ALLERGIC RHINITIS Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global PERENNIAL ALLERGIC RHINITIS Market Analysis and Forecast, By Drug-Class 7.1. Introduction and Definition 7.2. Key Findings 7.3. PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Drug-Class 7.4. PERENNIAL ALLERGIC RHINITIS Market Size (US$ Mn) Forecast, By Drug-Class 7.5. PERENNIAL ALLERGIC RHINITIS Market Analysis, By Drug-Class 7.6. PERENNIAL ALLERGIC RHINITIS Market Attractiveness Analysis, By Drug-Class 8. Global PERENNIAL ALLERGIC RHINITIS Market Analysis and Forecast, By Route of Administration 8.1. Introduction and Definition 8.2. Key Findings 8.3. PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Route of Administration 8.4. PERENNIAL ALLERGIC RHINITIS Market Size (US$ Mn) Forecast, By Route of Administration 8.5. PERENNIAL ALLERGIC RHINITIS Market Analysis, By Route of Administration 8.6. PERENNIAL ALLERGIC RHINITIS Market Attractiveness Analysis, By Route of Administration 9. Global PERENNIAL ALLERGIC RHINITIS Market Analysis and Forecast By Distribution Channels 9.1. Introduction and Definition 9.2. Key Findings 9.3. PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Distribution Channels 9.4. PERENNIAL ALLERGIC RHINITIS Market Size (US$ Mn) Forecast, By Distribution Channels 9.5. PERENNIAL ALLERGIC RHINITIS Market Analysis, By Distribution Channels 9.6. PERENNIAL ALLERGIC RHINITIS Market Attractiveness Analysis, By Distribution Channels 10. Global PERENNIAL ALLERGIC RHINITIS Market Analysis, By Region 10.1. PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Region 10.2. PERENNIAL ALLERGIC RHINITIS Market Size (US$ Mn) Forecast, By Region 10.3. PERENNIAL ALLERGIC RHINITIS Market Attractiveness Analysis, By Region 11. North America PERENNIAL ALLERGIC RHINITIS Market Analysis 11.1. Key Findings 11.2. North America PERENNIAL ALLERGIC RHINITIS Market Overview 11.3. North America PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Drug-Class 11.4. North America PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 11.4.1. Anti- Histamines 11.4.2. Steroids 11.4.3. Decongestants 11.4.4. Allergen Immunotherapy formulations 11.4.5. Others 11.5. North America PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Route of Administration 11.6. North America PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 11.6.1. Oral 11.6.2. Nasal 11.6.3. Intraocular 11.6.4. Intravenous 11.7. North America PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Distribution Channels 11.8. North America PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 11.8.1. Hospital pharmacies 11.8.2. Retail pharmacies 11.8.3. Online stores 11.9. North America PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Country 11.10. North America PERENNIAL ALLERGIC RHINITIS Market Forecast, By Country 11.10.1. U.S. 11.10.2. Canada 11.10.3. Mexico 11.11. North America PERENNIAL ALLERGIC RHINITIS Market Analysis, By Country 11.12. U.S. PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 11.12.1. Anti- Histamines 11.12.2. Steroids 11.12.3. Decongestants 11.12.4. Allergen Immunotherapy formulations 11.12.5. Others 11.13. U.S. PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 11.13.1. Oral 11.13.2. Nasal 11.13.3. Intraocular 11.13.4. Intravenous 11.14. U.S. PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 11.14.1. Hospital pharmacies 11.14.2. Retail pharmacies 11.14.3. Online stores 11.15. Canada PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 11.15.1. Anti- Histamines 11.15.2. Steroids 11.15.3. Decongestants 11.15.4. Allergen Immunotherapy formulations 11.15.5. Others 11.16. Canada PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 11.16.1. Oral 11.16.2. Nasal 11.16.3. Intraocular 11.16.4. Intravenous 11.17. Canada PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 11.17.1. Hospital pharmacies 11.17.2. Retail pharmacies 11.17.3. Online stores 11.18. Mexico PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 11.18.1. Anti- Histamines 11.18.2. Steroids 11.18.3. Decongestants 11.18.4. Allergen Immunotherapy formulations 11.18.5. Others 11.19. Mexico PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 11.19.1. Oral 11.19.2. Nasal 11.19.3. Intraocular 11.19.4. Intravenous 11.20. Mexico PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 11.20.1. Hospital pharmacies 11.20.2. Retail pharmacies 11.20.3. Online stores 11.21. North America PERENNIAL ALLERGIC RHINITIS Market Attractiveness Analysis 11.21.1. By Drug-Class 11.21.2. By Route of Administration 11.21.3. By Distribution Channels 11.22. PEST Analysis 11.23. Key Trends 11.24. Key Developments 12. Europe PERENNIAL ALLERGIC RHINITIS Market Analysis 12.1. Key Findings 12.2. Europe PERENNIAL ALLERGIC RHINITIS Market Overview 12.3. Europe PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Drug-Class 12.4. Europe PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 12.4.1. Anti- Histamines 12.4.2. Steroids 12.4.3. Decongestants 12.4.4. Allergen Immunotherapy formulations 12.4.5. Others 12.5. Europe PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Route of Administration 12.6. Europe PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 12.6.1. Oral 12.6.2. Nasal 12.6.3. Intraocular 12.6.4. Intravenous 12.7. Europe PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Distribution Channels 12.8. Europe PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 12.8.1. Hospital pharmacies 12.8.2. Retail pharmacies 12.8.3. Online stores 12.9. Europe PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Country 12.10. Europe PERENNIAL ALLERGIC RHINITIS Market Forecast, By Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Sweden 12.10.7. CIS countries 12.10.8. Rest of Europe 12.11. Germany PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 12.11.1. Anti- Histamines 12.11.2. Steroids 12.11.3. Decongestants 12.11.4. Allergen Immunotherapy formulations 12.11.5. Others 12.12. Germany PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 12.12.1. Oral 12.12.2. Nasal 12.12.3. Intraocular 12.12.4. Intravenous 12.13. Germany PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 12.13.1. Hospital pharmacies 12.13.2. Retail pharmacies 12.13.3. Online stores 12.14. U.K. PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 12.14.1. Anti- Histamines 12.14.2. Steroids 12.14.3. Decongestants 12.14.4. Allergen Immunotherapy formulations 12.14.5. Others 12.15. U.K. PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 12.15.1. Oral 12.15.2. Nasal 12.15.3. Intraocular 12.15.4. Intravenous 12.16. U.K. PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 12.16.1. Hospital pharmacies 12.16.2. Retail pharmacies 12.16.3. Online stores 12.17. France PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 12.17.1. Anti- Histamines 12.17.2. Steroids 12.17.3. Decongestants 12.17.4. Allergen Immunotherapy formulations 12.17.5. Others 12.18. France PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 12.18.1. Oral 12.18.2. Nasal 12.18.3. Intraocular 12.18.4. Intravenous 12.19. France PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 12.19.1. Hospital pharmacies 12.19.2. Retail pharmacies 12.19.3. Online stores 12.20. Italy PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 12.20.1. Anti- Histamines 12.20.2. Steroids 12.20.3. Decongestants 12.20.4. Allergen Immunotherapy formulations 12.20.5. Others 12.21. Italy PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 12.21.1. Oral 12.21.2. Nasal 12.21.3. Intraocular 12.21.4. Intravenous 12.22. Italy PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 12.22.1. Hospital pharmacies 12.22.2. Retail pharmacies 12.22.3. Online stores 12.23. Spain PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 12.23.1. Anti- Histamines 12.23.2. Steroids 12.23.3. Decongestants 12.23.4. Allergen Immunotherapy formulations 12.23.5. Others 12.24. Spain PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 12.24.1. Oral 12.24.2. Nasal 12.24.3. Intraocular 12.24.4. Intravenous 12.25. Spain PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 12.25.1. Hospital pharmacies 12.25.2. Retail pharmacies 12.25.3. Online stores 12.26. Sweden PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 12.26.1. Anti- Histamines 12.26.2. Steroids 12.26.3. Decongestants 12.26.4. Allergen Immunotherapy formulations 12.26.5. Others 12.27. Sweden PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 12.27.1. Oral 12.27.2. Nasal 12.27.3. Intraocular 12.27.4. Intravenous 12.28. Sweden PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 12.28.1. Hospital pharmacies 12.28.2. Retail pharmacies 12.28.3. Online stores 12.29. CIS countries PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 12.29.1. Anti- Histamines 12.29.2. Steroids 12.29.3. Decongestants 12.29.4. Allergen Immunotherapy formulations 12.29.5. Others 12.30. CIS countries PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 12.30.1. Oral 12.30.2. Nasal 12.30.3. Intraocular 12.30.4. Intravenous 12.31. CIS countries PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 12.31.1. Hospital pharmacies 12.31.2. Retail pharmacies 12.31.3. Online stores 12.32. Rest of Europe PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 12.32.1. Anti- Histamines 12.32.2. Steroids 12.32.3. Decongestants 12.32.4. Allergen Immunotherapy formulations 12.32.5. Others 12.33. Rest of Europe PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 12.33.1. Oral 12.33.2. Nasal 12.33.3. Intraocular 12.33.4. Intravenous 12.34. Rest of Europe PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 12.34.1. Hospital pharmacies 12.34.2. Retail pharmacies 12.34.3. Online stores 12.35. Europe PERENNIAL ALLERGIC RHINITIS Market Attractiveness Analysis 12.35.1. By Route of Administration 12.35.2. By Drug-Class 12.35.3. By Distribution Channels 12.36. PEST Analysis 12.37. Key Trends 12.38. Key Developments 13. Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Analysis 13.1. Key Findings 13.2. Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Overview 13.3. Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Drug-Class 13.4. Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 13.4.1. Anti- Histamines 13.4.2. Steroids 13.4.3. Decongestants 13.4.4. Allergen Immunotherapy formulations 13.4.5. Others 13.5. Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Route of Administration 13.6. Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 13.6.1. Oral 13.6.2. Nasal 13.6.3. Intraocular 13.6.4. Intravenous 13.7. Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Distribution Channels 13.8. Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 13.8.1. Hospital pharmacies 13.8.2. Retail pharmacies 13.8.3. Online stores 13.9. Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Country 13.10. Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Forecast, By Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. ASEAN 13.10.7. Rest of Asia Pacific 13.11. Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Analysis, By Country 13.12. China PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 13.12.1. Anti- Histamines 13.12.2. Steroids 13.12.3. Decongestants 13.12.4. Allergen Immunotherapy formulations 13.12.5. Others 13.13. China PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 13.13.1. Oral 13.13.2. Nasal 13.13.3. Intraocular 13.13.4. Intravenous 13.14. China PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 13.14.1. Hospital pharmacies 13.14.2. Retail pharmacies 13.14.3. Online stores 13.15. India PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 13.15.1. Anti- Histamines 13.15.2. Steroids 13.15.3. Decongestants 13.15.4. Allergen Immunotherapy formulations 13.15.5. Others 13.16. India PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 13.16.1. Oral 13.16.2. Nasal 13.16.3. Intraocular 13.16.4. Intravenous 13.17. India PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 13.17.1. Hospital pharmacies 13.17.2. Retail pharmacies 13.17.3. Online stores 13.18. Japan PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 13.18.1. Anti- Histamines 13.18.2. Steroids 13.18.3. Decongestants 13.18.4. Allergen Immunotherapy formulations 13.18.5. Others 13.19. Japan PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 13.19.1. Oral 13.19.2. Nasal 13.19.3. Intraocular 13.19.4. Intravenous 13.20. Japan PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 13.20.1. Hospital pharmacies 13.20.2. Retail pharmacies 13.20.3. Online stores 13.21. South Korea PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 13.21.1. Anti- Histamines 13.21.2. Steroids 13.21.3. Decongestants 13.21.4. Allergen Immunotherapy formulations 13.21.5. Others 13.22. South Korea PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 13.22.1. Oral 13.22.2. Nasal 13.22.3. Intraocular 13.22.4. Intravenous 13.23. South Korea PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 13.23.1. Hospital pharmacies 13.23.2. Retail pharmacies 13.23.3. Online stores 13.24. Australia PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 13.24.1. Anti- Histamines 13.24.2. Steroids 13.24.3. Decongestants 13.24.4. Allergen Immunotherapy formulations 13.24.5. Others 13.25. Australia PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 13.25.1. Oral 13.25.2. Nasal 13.25.3. Intraocular 13.25.4. Intravenous 13.26. Australia PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 13.26.1. Hospital pharmacies 13.26.2. Retail pharmacies 13.26.3. Online stores 13.27. ASEAN PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 13.27.1. Anti- Histamines 13.27.2. Steroids 13.27.3. Decongestants 13.27.4. Allergen Immunotherapy formulations 13.27.5. Others 13.28. ASEAN PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 13.28.1. Oral 13.28.2. Nasal 13.28.3. Intraocular 13.28.4. Intravenous 13.29. ASEAN PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 13.29.1. Hospital pharmacies 13.29.2. Retail pharmacies 13.29.3. Online stores 13.30. Rest of Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 13.30.1. Anti- Histamines 13.30.2. Steroids 13.30.3. Decongestants 13.30.4. Allergen Immunotherapy formulations 13.30.5. Others 13.31. Rest of Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 13.31.1. Oral 13.31.2. Nasal 13.31.3. Intraocular 13.31.4. Intravenous 13.32. Rest of Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 13.32.1. Hospital pharmacies 13.32.2. Retail pharmacies 13.32.3. Online stores 13.33. Asia Pacific PERENNIAL ALLERGIC RHINITIS Market Attractiveness Analysis 13.33.1. By Drug-Class 13.33.2. By Route of Administration 13.33.3. By Distribution Channels 13.34. PEST Analysis 13.35. Key Trends 13.36. Key Developments 14. Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Analysis 14.1. Key Findings 14.2. Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Overview 14.3. Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Drug-Class 14.4. Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 14.4.1. Anti- Histamines 14.4.2. Steroids 14.4.3. Decongestants 14.4.4. Allergen Immunotherapy formulations 14.4.5. Others 14.5. Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Route of Administration 14.6. Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 14.6.1. Oral 14.6.2. Nasal 14.6.3. Intraocular 14.6.4. Intravenous 14.7. Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Distribution Channels 14.8. Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 14.8.1. Hospital pharmacies 14.8.2. Retail pharmacies 14.8.3. Online stores 14.9. Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Country 14.10. Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Forecast, By Country 14.10.1. GCC Countries 14.10.2. South Africa 14.10.3. Nigeria 14.10.4. Egypt 14.10.5. Rest of Middle East & Africa 14.11. Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Analysis, By Country 14.12. GCC Countries PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 14.12.1. Anti- Histamines 14.12.2. Steroids 14.12.3. Decongestants 14.12.4. Allergen Immunotherapy formulations 14.12.5. Others 14.13. GCC Countries PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 14.13.1. Oral 14.13.2. Nasal 14.13.3. Intraocular 14.13.4. Intravenous 14.14. GCC Countries PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 14.14.1. Hospital pharmacies 14.14.2. Retail pharmacies 14.14.3. Online stores 14.15. South Africa PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 14.15.1. Anti- Histamines 14.15.2. Steroids 14.15.3. Decongestants 14.15.4. Allergen Immunotherapy formulations 14.15.5. Others 14.16. South Africa PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 14.16.1. Oral 14.16.2. Nasal 14.16.3. Intraocular 14.16.4. Intravenous 14.17. South Africa PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 14.17.1. Hospital pharmacies 14.17.2. Retail pharmacies 14.17.3. Online stores 14.18. Nigeria PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 14.18.1. Anti- Histamines 14.18.2. Steroids 14.18.3. Decongestants 14.18.4. Allergen Immunotherapy formulations 14.18.5. Others 14.19. Nigeria PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 14.19.1. Oral 14.19.2. Nasal 14.19.3. Intraocular 14.19.4. Intravenous 14.20. Nigeria PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 14.20.1. Hospital pharmacies 14.20.2. Retail pharmacies 14.20.3. Online stores 14.21. Egypt PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 14.21.1. Anti- Histamines 14.21.2. Steroids 14.21.3. Decongestants 14.21.4. Allergen Immunotherapy formulations 14.21.5. Others 14.22. Egypt PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 14.22.1. Oral 14.22.2. Nasal 14.22.3. Intraocular 14.22.4. Intravenous 14.23. Egypt PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 14.23.1. Hospital pharmacies 14.23.2. Retail pharmacies 14.23.3. Online stores 14.24. Rest of Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 14.24.1. Anti- Histamines 14.24.2. Steroids 14.24.3. Decongestants 14.24.4. Allergen Immunotherapy formulations 14.24.5. Others 14.25. Rest of Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 14.25.1. Oral 14.25.2. Nasal 14.25.3. Intraocular 14.25.4. Intravenous 14.26. Rest of Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 14.26.1. Hospital pharmacies 14.26.2. Retail pharmacies 14.26.3. Online stores 14.27. Middle East & Africa PERENNIAL ALLERGIC RHINITIS Market Attractiveness Analysis 14.27.1. By Drug-Class 14.27.2. By Route of Administration 14.27.3. By Distribution Channels 14.28. PEST Analysis 14.29. Key Trends 14.30. Key Developments 15. South America PERENNIAL ALLERGIC RHINITIS Market Analysis 15.1. Key Findings 15.2. South America PERENNIAL ALLERGIC RHINITIS Market Overview 15.3. South America PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Drug-Class 15.4. South America PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 15.4.1. Anti- Histamines 15.4.2. Steroids 15.4.3. Decongestants 15.4.4. Allergen Immunotherapy formulations 15.4.5. Others 15.5. South America PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Route of Administration 15.6. South America PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 15.6.1. Oral 15.6.2. Nasal 15.6.3. Intraocular 15.6.4. Intravenous 15.7. South America PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Distribution Channels 15.8. South America PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 15.8.1. Hospital pharmacies 15.8.2. Retail pharmacies 15.8.3. Online stores 15.9. South America PERENNIAL ALLERGIC RHINITIS Market Value Share Analysis, By Country 15.10. South America PERENNIAL ALLERGIC RHINITIS Market Forecast, By Country 15.10.1. Brazil 15.10.2. Colombia 15.10.3. Argentina 15.10.4. Rest of South America 15.11. South America PERENNIAL ALLERGIC RHINITIS Market Analysis, By Country 15.12. Brazil PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 15.12.1. Anti- Histamines 15.12.2. Steroids 15.12.3. Decongestants 15.12.4. Allergen Immunotherapy formulations 15.12.5. Others 15.13. Brazil PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 15.13.1. Oral 15.13.2. Nasal 15.13.3. Intraocular 15.13.4. Intravenous 15.14. Brazil PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 15.14.1. Hospital pharmacies 15.14.2. Retail pharmacies 15.14.3. Online stores 15.15. Colombia PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 15.15.1. Anti- Histamines 15.15.2. Steroids 15.15.3. Decongestants 15.15.4. Allergen Immunotherapy formulations 15.15.5. Others 15.16. Colombia PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 15.16.1. Oral 15.16.2. Nasal 15.16.3. Intraocular 15.16.4. Intravenous 15.17. Colombia PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 15.17.1. Hospital pharmacies 15.17.2. Retail pharmacies 15.17.3. Online stores 15.18. Argentina PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 15.18.1. Anti- Histamines 15.18.2. Steroids 15.18.3. Decongestants 15.18.4. Allergen Immunotherapy formulations 15.18.5. Others 15.19. Argentina PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 15.19.1. Oral 15.19.2. Nasal 15.19.3. Intraocular 15.19.4. Intravenous 15.20. Argentina PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 15.20.1. Hospital pharmacies 15.20.2. Retail pharmacies 15.20.3. Online stores 15.21. Rest of South America PERENNIAL ALLERGIC RHINITIS Market Forecast, By Drug-Class 15.21.1. Anti- Histamines 15.21.2. Steroids 15.21.3. Decongestants 15.21.4. Allergen Immunotherapy formulations 15.21.5. Others 15.22. Rest of South America PERENNIAL ALLERGIC RHINITIS Market Forecast, By Route of Administration 15.22.1. Oral 15.22.2. Nasal 15.22.3. Intraocular 15.22.4. Intravenous 15.23. Rest of South America PERENNIAL ALLERGIC RHINITIS Market Forecast, By Distribution Channels 15.23.1. Hospital pharmacies 15.23.2. Retail pharmacies 15.23.3. Online stores 15.24. South America PERENNIAL ALLERGIC RHINITIS Market Attractiveness Analysis 15.24.1. By Drug-Class 15.24.2. By Route of Administration 15.24.3. By Distribution Channels 15.25. PEST Analysis 15.26. Key Trends 15.27. Key Developments 16. Company Profiles 16.1. Market Share Analysis, By Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players By price, presence, market share, Component, and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A By Regions, Investment and Component 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Alcon Inc. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Merck & Co. Inc. 16.3.3. Biopharma 16.3.4. Sumitomo Pharma Co. 16.3.5. Genentech Inc. 16.3.6. Pfizer Inc. 16.3.7. Hanmi Pharmaceuticals Inc. 16.3.8. Hisamitsu Pharmaceutical Co. 16.3.9. Teva pharmaceutical 16.3.10. GlaxoSmithKline PLC 16.3.11. Sanofi S.A. 16.3.12. Johnson & Johnson 16.3.13. AstraZeneca 16.3.14. Boehringer Ingelheim 17. Primary key Insights